ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "74b7d266-5234-465e-b7e1-3b783007f6d1"}, "_deposit": {"id": "22677", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "22677"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00022677", "sets": ["456", "1203"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "The Thrapeutic Model of Systemic Lupus Erythematosus(Autoimmune Diseases)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1989-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "982", "bibliographicPageStart": "977", "bibliographicVolumeNumber": "103", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The therapeutic effect of 15-deoxyspergualin (DSP), a newly developed immunosuppressive agent, on the development of spontaneously occuring lupus glomerulonephritis in MRL/1pr and male BXSB mice was examined. Administration of the drug was begun from the age of 13 weeks, when polyclonal B cell activation and lupus nephropathy were apparent. Treatment with DSP up to 20 weeks of age at a dose of 2mg/kg twice a day, 5mg/kg daily or 20mg/kg three times a week strongly suppressed the increment of IgG-producing cell numbers in the spleen, and decreased serum levels of immune complexes and anti-DNA antibodies. Glomerular histological score by light microscopy and IgG and C3 deposition estimated by immunofluorescence were remarkably improved. In MRL/1pr mice, DSP reduced the swelling of lymph node and the numbers of Thy-1^+, B220^+ cell population in lymphoid organs. Responsiveness to Con A and IL-2 production of spleen cells were improved by the treatment. Thus, DSP was shown to suppress the progression of polyclonal B cell activation and lupus nephropathy in MRL/1pr and male BXSB mice. These results suggest that DSP might be used as a therapeutic agent for human erythematosus.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "137505", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Ito, Satoshi"}]}, {"nameIdentifiers": [{"nameIdentifier": "137506", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Fujiwara, Michio"}]}, {"nameIdentifiers": [{"nameIdentifier": "137507", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Arakawa, Masaaki"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "伊藤, 聡"}], "nameIdentifiers": [{"nameIdentifier": "137502", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "藤原, 道夫"}], "nameIdentifiers": [{"nameIdentifier": "137503", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "荒川, 正昭"}], "nameIdentifiers": [{"nameIdentifier": "137504", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "103(12)_977-982.pdf", "filesize": [{"value": "2.6 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 2600000.0, "url": {"label": "103(12)_977-982.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/22677/files/103(12)_977-982.pdf"}, "version_id": "b161f1f5-bd68-4704-b151-f927e1dbdf83"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Murine Lupus", "subitem_subject_scheme": "Other"}, {"subitem_subject": "MRL/1pr mice", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Male BXSB mice", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Polyclonal B cell activation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Immunosuppressant", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ループスモデルマウス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "MRL/1prマウス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "BXSB雄マウス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "多クローン性B細胞活性化", "subitem_subject_scheme": "Other"}, {"subitem_subject": "免疫抑制剤", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)"}, {"subitem_title": "4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1203"], "permalink_uri": "http://hdl.handle.net/10191/41469", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-04-13"}, "publish_date": "2016-04-13", "publish_status": "0", "recid": "22677", "relation": {}, "relation_version_is_last": true, "title": ["4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)"], "weko_shared_id": null}
  1. 0 資料タイプ別
  2. 03 紀要論文
  1. 250 大学院医歯学総合研究科(医)
  2. 20 紀要
  3. 02 新潟医学会雑誌
  4. 第103巻第12号

4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)

http://hdl.handle.net/10191/41469
http://hdl.handle.net/10191/41469
9d6c16ba-e00e-4619-a2a5-2efc9be93d90
名前 / ファイル ライセンス アクション
103(12)_977-982.pdf 103(12)_977-982.pdf (2.6 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2016-04-13
タイトル
タイトル 4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)
タイトル
言語 en
タイトル 4) エリテマトーデスの治療モデル(シンポジウム 自己免疫疾患, 第445回新潟医学会)
言語
言語 jpn
キーワード
主題Scheme Other
主題 Murine Lupus
キーワード
主題Scheme Other
主題 MRL/1pr mice
キーワード
主題Scheme Other
主題 Male BXSB mice
キーワード
主題Scheme Other
主題 Polyclonal B cell activation
キーワード
主題Scheme Other
主題 Immunosuppressant
キーワード
主題Scheme Other
主題 ループスモデルマウス
キーワード
主題Scheme Other
主題 MRL/1prマウス
キーワード
主題Scheme Other
主題 BXSB雄マウス
キーワード
主題Scheme Other
主題 多クローン性B細胞活性化
キーワード
主題Scheme Other
主題 免疫抑制剤
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
その他のタイトル
その他のタイトル The Thrapeutic Model of Systemic Lupus Erythematosus(Autoimmune Diseases)
著者 伊藤, 聡

× 伊藤, 聡

WEKO 137502

伊藤, 聡

Search repository
藤原, 道夫

× 藤原, 道夫

WEKO 137503

藤原, 道夫

Search repository
荒川, 正昭

× 荒川, 正昭

WEKO 137504

荒川, 正昭

Search repository
著者別名
識別子 137505
識別子Scheme WEKO
姓名 Ito, Satoshi
著者別名
識別子 137506
識別子Scheme WEKO
姓名 Fujiwara, Michio
著者別名
識別子 137507
識別子Scheme WEKO
姓名 Arakawa, Masaaki
抄録
内容記述タイプ Abstract
内容記述 The therapeutic effect of 15-deoxyspergualin (DSP), a newly developed immunosuppressive agent, on the development of spontaneously occuring lupus glomerulonephritis in MRL/1pr and male BXSB mice was examined. Administration of the drug was begun from the age of 13 weeks, when polyclonal B cell activation and lupus nephropathy were apparent. Treatment with DSP up to 20 weeks of age at a dose of 2mg/kg twice a day, 5mg/kg daily or 20mg/kg three times a week strongly suppressed the increment of IgG-producing cell numbers in the spleen, and decreased serum levels of immune complexes and anti-DNA antibodies. Glomerular histological score by light microscopy and IgG and C3 deposition estimated by immunofluorescence were remarkably improved. In MRL/1pr mice, DSP reduced the swelling of lymph node and the numbers of Thy-1^+, B220^+ cell population in lymphoid organs. Responsiveness to Con A and IL-2 production of spleen cells were improved by the treatment. Thus, DSP was shown to suppress the progression of polyclonal B cell activation and lupus nephropathy in MRL/1pr and male BXSB mice. These results suggest that DSP might be used as a therapeutic agent for human erythematosus.
書誌情報 新潟医学会雑誌
en : 新潟医学会雑誌

巻 103, 号 12, p. 977-982, 発行日 1989-12
出版者
出版者 新潟医学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 00290440
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00182415
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 13:13:04.638122
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3